ACADIA Pharmaceuticals (NASDAQ:ACAD) Downgraded by StockNews.com to “Hold”
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Friday. A number of other research firms have also weighed in on ACAD. Deutsche Bank Aktiengesellschaft started coverage on shares of ACADIA Pharmaceuticals in a research report on Tuesday, February […]
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Friday. A number of other research firms have also weighed in on ACAD. Deutsche Bank Aktiengesellschaft started coverage on shares of ACADIA Pharmaceuticals in a research report on Tuesday, February […]
